Long Acting Drug Delivery Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: L145463E8C56EN
Market Monitor Global

Abstracts

Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.

This report contains market size and forecasts of Long Acting Drug Delivery in Global, including the following market information:

Global Long Acting Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Long Acting Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Long Acting Drug Delivery include ViiV Healthcare, Halozyme Therapeutics, Lubrizol Life Science, Celanese Corporation, Kashiv BioSciences, 4P Therapeutics, Ipsen, Midatech Pharma and Re-Vana Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Long Acting Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Long Acting Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Long Acting Drug Delivery Market Segment Percentages, by Type, 2021 (%)

• Device
• Parenteral Injections

Global Long Acting Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Long Acting Drug Delivery Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Specialty Clinics
• Clinical Research Institutes
• Others

Global Long Acting Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Long Acting Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Long Acting Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Long Acting Drug Delivery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ViiV Healthcare
• Halozyme Therapeutics
• Lubrizol Life Science
• Celanese Corporation
• Kashiv BioSciences
• 4P Therapeutics
• Ipsen
• Midatech Pharma
• Re-Vana Therapeutics
• Creative Biolabs

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Long Acting Drug Delivery Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Long Acting Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LONG ACTING DRUG DELIVERY OVERALL MARKET SIZE

2.1 Global Long Acting Drug Delivery Market Size: 2021 VS 2028
2.2 Global Long Acting Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Long Acting Drug Delivery Players in Global Market
3.2 Top Global Long Acting Drug Delivery Companies Ranked by Revenue
3.3 Global Long Acting Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Long Acting Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Long Acting Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Long Acting Drug Delivery Players in Global Market
  3.6.1 List of Global Tier 1 Long Acting Drug Delivery Companies
  3.6.2 List of Global Tier 2 and Tier 3 Long Acting Drug Delivery Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Long Acting Drug Delivery Market Size Markets, 2021 & 2028
  4.1.2 Device
  4.1.3 Parenteral Injections
4.2 By Type - Global Long Acting Drug Delivery Revenue & Forecasts
  4.2.1 By Type - Global Long Acting Drug Delivery Revenue, 2017-2022
  4.2.2 By Type - Global Long Acting Drug Delivery Revenue, 2023-2028
  4.2.3 By Type - Global Long Acting Drug Delivery Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Long Acting Drug Delivery Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Specialty Clinics
  5.1.4 Clinical Research Institutes
  5.1.5 Others
5.2 By Application - Global Long Acting Drug Delivery Revenue & Forecasts
  5.2.1 By Application - Global Long Acting Drug Delivery Revenue, 2017-2022
  5.2.2 By Application - Global Long Acting Drug Delivery Revenue, 2023-2028
  5.2.3 By Application - Global Long Acting Drug Delivery Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Long Acting Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Long Acting Drug Delivery Revenue & Forecasts
  6.2.1 By Region - Global Long Acting Drug Delivery Revenue, 2017-2022
  6.2.2 By Region - Global Long Acting Drug Delivery Revenue, 2023-2028
  6.2.3 By Region - Global Long Acting Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Long Acting Drug Delivery Revenue, 2017-2028
  6.3.2 US Long Acting Drug Delivery Market Size, 2017-2028
  6.3.3 Canada Long Acting Drug Delivery Market Size, 2017-2028
  6.3.4 Mexico Long Acting Drug Delivery Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Long Acting Drug Delivery Revenue, 2017-2028
  6.4.2 Germany Long Acting Drug Delivery Market Size, 2017-2028
  6.4.3 France Long Acting Drug Delivery Market Size, 2017-2028
  6.4.4 U.K. Long Acting Drug Delivery Market Size, 2017-2028
  6.4.5 Italy Long Acting Drug Delivery Market Size, 2017-2028
  6.4.6 Russia Long Acting Drug Delivery Market Size, 2017-2028
  6.4.7 Nordic Countries Long Acting Drug Delivery Market Size, 2017-2028
  6.4.8 Benelux Long Acting Drug Delivery Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Long Acting Drug Delivery Revenue, 2017-2028
  6.5.2 China Long Acting Drug Delivery Market Size, 2017-2028
  6.5.3 Japan Long Acting Drug Delivery Market Size, 2017-2028
  6.5.4 South Korea Long Acting Drug Delivery Market Size, 2017-2028
  6.5.5 Southeast Asia Long Acting Drug Delivery Market Size, 2017-2028
  6.5.6 India Long Acting Drug Delivery Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Long Acting Drug Delivery Revenue, 2017-2028
  6.6.2 Brazil Long Acting Drug Delivery Market Size, 2017-2028
  6.6.3 Argentina Long Acting Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Long Acting Drug Delivery Revenue, 2017-2028
  6.7.2 Turkey Long Acting Drug Delivery Market Size, 2017-2028
  6.7.3 Israel Long Acting Drug Delivery Market Size, 2017-2028
  6.7.4 Saudi Arabia Long Acting Drug Delivery Market Size, 2017-2028
  6.7.5 UAE Long Acting Drug Delivery Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 ViiV Healthcare
  7.1.1 ViiV Healthcare Corporate Summary
  7.1.2 ViiV Healthcare Business Overview
  7.1.3 ViiV Healthcare Long Acting Drug Delivery Major Product Offerings
  7.1.4 ViiV Healthcare Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.1.5 ViiV Healthcare Key News
7.2 Halozyme Therapeutics
  7.2.1 Halozyme Therapeutics Corporate Summary
  7.2.2 Halozyme Therapeutics Business Overview
  7.2.3 Halozyme Therapeutics Long Acting Drug Delivery Major Product Offerings
  7.2.4 Halozyme Therapeutics Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.2.5 Halozyme Therapeutics Key News
7.3 Lubrizol Life Science
  7.3.1 Lubrizol Life Science Corporate Summary
  7.3.2 Lubrizol Life Science Business Overview
  7.3.3 Lubrizol Life Science Long Acting Drug Delivery Major Product Offerings
  7.3.4 Lubrizol Life Science Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.3.5 Lubrizol Life Science Key News
7.4 Celanese Corporation
  7.4.1 Celanese Corporation Corporate Summary
  7.4.2 Celanese Corporation Business Overview
  7.4.3 Celanese Corporation Long Acting Drug Delivery Major Product Offerings
  7.4.4 Celanese Corporation Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.4.5 Celanese Corporation Key News
7.5 Kashiv BioSciences
  7.5.1 Kashiv BioSciences Corporate Summary
  7.5.2 Kashiv BioSciences Business Overview
  7.5.3 Kashiv BioSciences Long Acting Drug Delivery Major Product Offerings
  7.5.4 Kashiv BioSciences Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.5.5 Kashiv BioSciences Key News
7.6 4P Therapeutics
  7.6.1 4P Therapeutics Corporate Summary
  7.6.2 4P Therapeutics Business Overview
  7.6.3 4P Therapeutics Long Acting Drug Delivery Major Product Offerings
  7.6.4 4P Therapeutics Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.6.5 4P Therapeutics Key News
7.7 Ipsen
  7.7.1 Ipsen Corporate Summary
  7.7.2 Ipsen Business Overview
  7.7.3 Ipsen Long Acting Drug Delivery Major Product Offerings
  7.7.4 Ipsen Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.7.5 Ipsen Key News
7.8 Midatech Pharma
  7.8.1 Midatech Pharma Corporate Summary
  7.8.2 Midatech Pharma Business Overview
  7.8.3 Midatech Pharma Long Acting Drug Delivery Major Product Offerings
  7.8.4 Midatech Pharma Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.8.5 Midatech Pharma Key News
7.9 Re-Vana Therapeutics
  7.9.1 Re-Vana Therapeutics Corporate Summary
  7.9.2 Re-Vana Therapeutics Business Overview
  7.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Major Product Offerings
  7.9.4 Re-Vana Therapeutics Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.9.5 Re-Vana Therapeutics Key News
7.10 Creative Biolabs
  7.10.1 Creative Biolabs Corporate Summary
  7.10.2 Creative Biolabs Business Overview
  7.10.3 Creative Biolabs Long Acting Drug Delivery Major Product Offerings
  7.10.4 Creative Biolabs Long Acting Drug Delivery Revenue in Global Market (2017-2022)
  7.10.5 Creative Biolabs Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Long Acting Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Long Acting Drug Delivery Market Drivers in Global Market
Table 3. Long Acting Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Long Acting Drug Delivery in Global Market
Table 5. Top Long Acting Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Long Acting Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Long Acting Drug Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Long Acting Drug Delivery Product Type
Table 9. List of Global Tier 1 Long Acting Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long Acting Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Long Acting Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Long Acting Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Long Acting Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Long Acting Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Long Acting Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Long Acting Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Long Acting Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Long Acting Drug Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Long Acting Drug Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Long Acting Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Long Acting Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Long Acting Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Long Acting Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Long Acting Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 30. ViiV Healthcare Corporate Summary
Table 31. ViiV Healthcare Long Acting Drug Delivery Product Offerings
Table 32. ViiV Healthcare Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 33. Halozyme Therapeutics Corporate Summary
Table 34. Halozyme Therapeutics Long Acting Drug Delivery Product Offerings
Table 35. Halozyme Therapeutics Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 36. Lubrizol Life Science Corporate Summary
Table 37. Lubrizol Life Science Long Acting Drug Delivery Product Offerings
Table 38. Lubrizol Life Science Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 39. Celanese Corporation Corporate Summary
Table 40. Celanese Corporation Long Acting Drug Delivery Product Offerings
Table 41. Celanese Corporation Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 42. Kashiv BioSciences Corporate Summary
Table 43. Kashiv BioSciences Long Acting Drug Delivery Product Offerings
Table 44. Kashiv BioSciences Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 45. 4P Therapeutics Corporate Summary
Table 46. 4P Therapeutics Long Acting Drug Delivery Product Offerings
Table 47. 4P Therapeutics Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Ipsen Corporate Summary
Table 49. Ipsen Long Acting Drug Delivery Product Offerings
Table 50. Ipsen Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 51. Midatech Pharma Corporate Summary
Table 52. Midatech Pharma Long Acting Drug Delivery Product Offerings
Table 53. Midatech Pharma Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 54. Re-Vana Therapeutics Corporate Summary
Table 55. Re-Vana Therapeutics Long Acting Drug Delivery Product Offerings
Table 56. Re-Vana Therapeutics Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 57. Creative Biolabs Corporate Summary
Table 58. Creative Biolabs Long Acting Drug Delivery Product Offerings
Table 59. Creative Biolabs Long Acting Drug Delivery Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Long Acting Drug Delivery Segment by Type in 2021
Figure 2. Long Acting Drug Delivery Segment by Application in 2021
Figure 3. Global Long Acting Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Long Acting Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Long Acting Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Long Acting Drug Delivery Revenue in 2021
Figure 8. By Type - Global Long Acting Drug Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Long Acting Drug Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Long Acting Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Long Acting Drug Delivery Revenue Market Share, 2017-2028
Figure 12. US Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Long Acting Drug Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Long Acting Drug Delivery Revenue Market Share, 2017-2028
Figure 24. China Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Long Acting Drug Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Long Acting Drug Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Long Acting Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. ViiV Healthcare Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Halozyme Therapeutics Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lubrizol Life Science Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Celanese Corporation Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Kashiv BioSciences Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. 4P Therapeutics Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Ipsen Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Midatech Pharma Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Re-Vana Therapeutics Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Creative Biolabs Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)